• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隆突性皮肤纤维肉瘤和皮肤纤维瘤中的CD34及凝血因子XIIIa免疫反应性

CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.

作者信息

Goldblum J R, Tuthill R J

机构信息

Department of Anatomic Pathology, Cleveland Clinic Foundation, OH 44195, USA.

出版信息

Am J Dermatopathol. 1997 Apr;19(2):147-53. doi: 10.1097/00000372-199704000-00008.

DOI:10.1097/00000372-199704000-00008
PMID:9129699
Abstract

The histologic distinction between dermatofibrosarcoma protuberans (DFSP) and the fibrous type of benign fibrous histiocytoma (dermatofibroma, DF) may be extremely difficult. In this study, we evaluated the extent and pattern of immunoreactivity of both CD34 and factor XIIIa in a large number of DFSPs and DFs in order to determine the utility of these markers in their distinction. Using histologic criteria alone, the authors independently evaluated and agreed upon 30 cases of DF and 24 cases of DFSP, and a representative section was stained with antibodies to both factor XIIIa and CD34. Immunopositivity was evaluated semiquantitatively and assigned a score from 0 to 5. CD34 immunoreactivity was seen in 22 (92%) of 24 DFSPs (mean CD34 score, 4.60 +/- 0.3). Only 12 (40%) of 30 DFs showed CD34 immunopositivity (mean CD34 score, 0.6 +/- 0.1). Factor XIIIa was seen in 29 (97%) of 30 DFs (mean factor-XIIIa score, 4.1 +/- 0.3). In contrast, 18 (75%) of 24 DFSPs stained for factor XIIIa (mean factor-XIIIa score, 1.3 +/- 0.2), but in most of these cases the factor-XIIIa-positive cells were felt to be entrapped nonneoplastic dermal dendrocytes. Thus, an immunoprofile using antibodies to CD34 and factor XIIIa is capable of distinguishing between DFSP and the fibrous type of DF in the vast majority of cases, as long as there is recognition that there may be some CD34-positive cells in DFs, as well as some factor-XIIIa-positive cells in DFSPs.

摘要

隆突性皮肤纤维肉瘤(DFSP)与纤维型良性纤维组织细胞瘤(皮肤纤维瘤,DF)之间的组织学鉴别可能极其困难。在本研究中,我们评估了大量DFSP和DF中CD34和因子ⅩⅢa的免疫反应程度和模式,以确定这些标志物在鉴别诊断中的效用。仅根据组织学标准,作者独立评估并认可了30例DF和24例DFSP,并对一个代表性切片用因子ⅩⅢa和CD34抗体进行染色。对免疫阳性进行半定量评估,并赋予0至5分的评分。24例DFSP中有22例(92%)可见CD34免疫反应(平均CD34评分,4.60±0.3)。30例DF中仅12例(40%)显示CD34免疫阳性(平均CD34评分,0.6±0.1)。30例DF中有29例(97%)可见因子ⅩⅢa(平均因子ⅩⅢa评分,4.1±0.3)。相比之下,24例DFSP中有18例(75%)因子ⅩⅢa染色阳性(平均因子ⅩⅢa评分,1.3±0.2),但在大多数这些病例中,因子ⅩⅢa阳性细胞被认为是陷入的非肿瘤性真皮树突状细胞。因此,只要认识到DF中可能存在一些CD34阳性细胞以及DFSP中可能存在一些因子ⅩⅢa阳性细胞,使用CD34和因子ⅩⅢa抗体的免疫表型在绝大多数病例中能够区分DFSP和纤维型DF。

相似文献

1
CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.隆突性皮肤纤维肉瘤和皮肤纤维瘤中的CD34及凝血因子XIIIa免疫反应性
Am J Dermatopathol. 1997 Apr;19(2):147-53. doi: 10.1097/00000372-199704000-00008.
2
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.HMGA1和HMGA2在皮肤纤维瘤和隆突性皮肤纤维肉瘤中的差异表达:潜在的诊断应用,以及与组织学结果、CD34和凝血因子XIIIa免疫反应性的比较
Am J Dermatopathol. 2004 Aug;26(4):267-72. doi: 10.1097/00000372-200408000-00001.
3
CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.CD34和凝血因子XIIIa在皮肤纤维瘤和隆突性皮肤纤维肉瘤鉴别诊断中的应用
Am J Dermatopathol. 1993 Oct;15(5):429-34. doi: 10.1097/00000372-199310000-00003.
4
Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.腱生蛋白可将皮肤纤维瘤与隆突性皮肤纤维肉瘤区分开来:与CD34和因子ⅩⅢa的比较
Hum Pathol. 2001 Jan;32(1):50-6. doi: 10.1053/hupa.2001.21137.
5
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.基质溶解素-3在皮肤纤维瘤和隆突性皮肤纤维肉瘤鉴别诊断中的表达:与ⅩⅢa因子和CD34的比较
Br J Dermatol. 2007 Aug;157(2):319-24. doi: 10.1111/j.1365-2133.2007.08033.x. Epub 2007 Jun 26.
6
Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.CD163在皮肤纤维瘤、细胞性纤维组织细胞瘤和隆突性皮肤纤维肉瘤中的表达:与CD68、CD34和因子ⅩⅢa的比较
J Cutan Pathol. 2006 May;33(5):353-60. doi: 10.1111/j.0303-6987.2006.00439.x.
7
The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.CD34和D2-40在皮肤纤维瘤和隆突性皮肤纤维肉瘤分化中的作用
Turk Patoloji Derg. 2017;1(1):223-227. doi: 10.5146/tjpath.2017.01402.
8
Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles.皮肤纤维瘤和隆突性皮肤纤维肉瘤:一项免疫组织化学研究揭示了独特的抗原谱。
J Dermatol Sci. 1996 Jan;11(1):1-9. doi: 10.1016/0923-1811(95)00409-2.
9
[Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans].
Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Aug 18;40(4):395-400.
10
Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?皮肤的不确定纤维组织细胞性病变:皮肤纤维瘤与隆突性皮肤纤维肉瘤之间是否存在连续谱系?
Am J Surg Pathol. 2000 Jul;24(7):996-1003. doi: 10.1097/00000478-200007000-00011.

引用本文的文献

1
Bednar's tumor at right shoulder in an adult male: a case report of a rare entity.成年男性右肩部的贝德纳氏瘤:罕见病例报告
Ann Med Surg (Lond). 2024 Jan 3;86(2):1196-1199. doi: 10.1097/MS9.0000000000001672. eCollection 2024 Feb.
2
Dermatofibrosarcoma protuberans: a case report of an abdominal wall mass and review of the literature.隆突性皮肤纤维肉瘤:腹壁肿块病例报告及文献复习
J Surg Case Rep. 2023 Oct 6;2023(10):rjad542. doi: 10.1093/jscr/rjad542. eCollection 2023 Oct.
3
Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis.
伴有CD34蛋白异常表达的皮肤纤维瘤:一项系统评价及对临床病理特征和组织发生的重新评估
Diagnostics (Basel). 2023 Jan 4;13(2):185. doi: 10.3390/diagnostics13020185.
4
PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans.PDGFB RNA 原位杂交在隆突性皮肤纤维肉瘤诊断中的应用。
Mod Pathol. 2021 Aug;34(8):1521-1529. doi: 10.1038/s41379-021-00800-2. Epub 2021 Mar 24.
5
Factor XIII-A in Diseases: Role Beyond Blood Coagulation.凝血因子 XIII-A 在疾病中的作用:超越血液凝固的角色。
Int J Mol Sci. 2021 Feb 1;22(3):1459. doi: 10.3390/ijms22031459.
6
A Clinicohistopathological Analysis of Cutaneous Fibrous Histiocytomas of the Finger.手指皮肤纤维组织细胞瘤的临床组织病理学分析
Indian J Dermatol. 2020 Sep-Oct;65(5):401-405. doi: 10.4103/ijd.IJD_366_18.
7
Unmasking dermatofibrosarcoma protuberans: Case report of an atypical presentation complicated by post-surgical excision.隐匿性隆突性皮肤纤维肉瘤:一例非典型表现并术后切除并发症的病例报告
Int J Surg Case Rep. 2020;69:101-104. doi: 10.1016/j.ijscr.2020.03.020. Epub 2020 Apr 3.
8
Recurrent Dermatofibrosarcoma with Pigmentation and Myoid Differentiation.伴有色素沉着及肌样分化的复发性皮肤纤维肉瘤
Sultan Qaboos Univ Med J. 2018 May;18(2):e228-e230. doi: 10.18295/squmj.2018.18.02.019. Epub 2018 Sep 9.
9
Immunohistochemistry in Dermatopathology and its Relevance in Clinical Practice.皮肤病理学中的免疫组织化学及其在临床实践中的相关性。
Indian Dermatol Online J. 2018 Jul-Aug;9(4):234-244. doi: 10.4103/idoj.IDOJ_8_18.
10
Fibrosarcomatous change in the background of dermatofibrosarcoma protuberans in male breast: Study of a rare case and review of the entity.男性乳腺隆突性皮肤纤维肉瘤背景下的纤维肉瘤样改变:1例罕见病例研究及该实体的文献复习
J Midlife Health. 2016 Jan-Mar;7(1):45-8. doi: 10.4103/0976-7800.179171.